日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma.

利用 DARPins 选择性靶向 TBXT 可识别脊索瘤的调控网络和治疗弱点

Umbaugh Charles S, Groth Marie, Erkut Cihan, Lee Kwang-Seok, Marinho Joana, Linder Simon, Iser Florian, Kapp Jonas N, Schroeter Petra, Dolaner Simay, Kayserili Asli, Helm Dominic, Schneider Martin, Hartmann Julia, Walch Philipp, Barth Thomas F E, Mellert Kevin, Dreier Birgit, Schaefer Jonas V, Plückthun Andreas, Fröhling Stefan, Scholl Claudia

Tau mediates the reshaping of the transcriptional landscape toward intermediate Alzheimer's disease stages

Tau 介导转录景观向阿尔茨海默病中期阶段的重塑

Giacomo Siano #, Martina Varisco #, Marco Terrigno, Congwei Wang, Arianna Scarlatti, Vincenzo Iannone, Marco Groth, Marie-Christine Galas, Jeroen J M Hoozemans, Alessandro Cellerino, Antonino Cattaneo, Cristina Di Primio

Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab

在接受奥法妥木单抗持续治疗的复发型多发性硬化症患者中,SARS-CoV-2 mRNA疫苗加强针接种后12个月的中和抗体滴度

Ziemssen, Tjalf; Groth, Marie; Ettle, Benjamin; Bopp, Tobias

Correction: Ziemssen et al. Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod-Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC). Vaccines 2023, 11, 1374

更正:Ziemssen 等人,《接受西尼莫德治疗的患者对 SARS-CoV-2 mRNA 疫苗初始和加强免疫接种的免疫反应——一项非随机对照临床试验的最终分析 (AMA-VACC)》,《疫苗》2023,11,1374

Ziemssen, Tjalf; Groth, Marie; Winkelmann, Veronika Eva; Bopp, Tobias

Addition of quantitative MRI to the routine clinical care of patients with multiple sclerosis-Results from the MAGNON project

将定量磁共振成像纳入多发性硬化症患者的常规临床护理——MAGNON项目的结果

Leussink, Verena Isabell; Jankovic, Manda; Groth, Marie; Schuh, Katrin; Sauerbeck, Inessa Schwab; Hoffmann, Olaf

Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod-Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC)

接受西尼莫德治疗的患者对 SARS-CoV-2 mRNA 疫苗初始接种和加强接种的免疫反应——非随机对照临床试验的最终分析 (AMA-VACC)

Ziemssen, Tjalf; Groth, Marie; Winkelmann, Veronika Eva; Bopp, Tobias

Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis

一项针对接受奥法妥木单抗治疗的复发型多发性硬化症患者的开放标签多中心研究,结果显示SARS-CoV-2 mRNA疫苗加强针的疗效

Ziemssen, Tjalf; Schlegel, Eugen; Groth, Marie; Ettle, Benjamin; Bopp, Tobias

Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC)

评估接受西尼莫德治疗的患者对 SARS-CoV-2 mRNA 疫苗的免疫反应:一项非随机对照临床试验 (AMA-VACC)

Ziemssen, Tjalf; Groth, Marie; Rauser, Benedict; Bopp, Tobias

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma

同源重组DNA修复缺陷可作为晚期脊索瘤的治疗靶点

Gröschel, Stefan; Hübschmann, Daniel; Raimondi, Francesco; Horak, Peter; Warsow, Gregor; Fröhlich, Martina; Klink, Barbara; Gieldon, Laura; Hutter, Barbara; Kleinheinz, Kortine; Bonekamp, David; Marschal, Oliver; Chudasama, Priya; Mika, Jagoda; Groth, Marie; Uhrig, Sebastian; Krämer, Stephen; Heining, Christoph; Heilig, Christoph E; Richter, Daniela; Reisinger, Eva; Pfütze, Katrin; Eils, Roland; Wolf, Stephan; von Kalle, Christof; Brandts, Christian; Scholl, Claudia; Weichert, Wilko; Richter, Stephan; Bauer, Sebastian; Penzel, Roland; Schröck, Evelin; Stenzinger, Albrecht; Schlenk, Richard F; Brors, Benedikt; Russell, Robert B; Glimm, Hanno; Schlesner, Matthias; Fröhling, Stefan

Replication stress links structural and numerical cancer chromosomal instability

复制压力将癌症染色体的结构和数量不稳定性联系起来

Rebecca A Burrell # ,Sarah E McClelland # ,David Endesfelder ,Petra Groth ,Marie-Christine Weller ,Nadeem Shaikh ,Enric Domingo ,Nnennaya Kanu ,Sally M Dewhurst ,Eva Gronroos ,Su Kit Chew ,Andrew J Rowan ,Arne Schenk ,Michal Sheffer ,Michael Howell ,Maik Kschischo ,Axel Behrens ,Thomas Helleday ,Jiri Bartek ,Ian P Tomlinson ,Charles Swanton